What are the drug interactions between amoxicillin‑clavulanic acid, methotrexate, and hydroxychloroquine?

Drug Interactions Between Amoxicillin-Clavulanic Acid, Methotrexate, and Hydroxychloroquine

Yes, there are clinically significant drug interactions between these medications that require careful monitoring and potential dose adjustments.

Critical Interaction: Amoxicillin-Clavulanic Acid and Methotrexate

Penicillins, including amoxicillin, can significantly increase methotrexate toxicity by reducing its renal clearance. This interaction occurs through two mechanisms 1:

• Decreased protein binding: Penicillins displace methotrexate from serum albumin, increasing free drug levels
• Reduced renal tubular secretion: Competition at the renal tubular secretion pathway decreases methotrexate elimination

Clinical Evidence

A case report documented severe toxicity when amoxicillin (1g every 6 hours) was co-administered with high-dose methotrexate 2. The patient experienced:

• Prolonged and markedly elevated methotrexate serum levels
• Renal failure
• Myelosuppression
• Mucositis
• Dermatologic abnormalities

The pharmacokinetic analysis showed significant alterations in total plasma clearance, mean residence time, and distribution half-life compared to methotrexate alone.

Management Recommendations

• Avoid concurrent use when possible 1
• If co-administration is unavoidable:
  • Monitor complete blood counts before each methotrexate dose
  • Check renal function (BUN, creatinine) closely
  • Monitor for signs of methotrexate toxicity (mucositis, myelosuppression, hepatotoxicity)
  • Consider dose reduction of methotrexate
  • Have leucovorin (folinic acid) readily available as antidote 1

Moderate Interaction: Hydroxychloroquine and Methotrexate

The FDA drug label explicitly states that concomitant use of hydroxychloroquine and methotrexate may increase the incidence of adverse reactions 3.

However, clinical research shows a more nuanced picture:

Pharmacokinetic Effects

A randomized crossover study in healthy volunteers found that hydroxychloroquine co-administration with methotrexate 4:

• Increased methotrexate AUC (area under curve) by approximately 60% (p=0.005)
• Decreased methotrexate Cmax (maximum concentration) (p=0.025)
• Delayed methotrexate tmax (time to maximum concentration) (p=0.072)

A related study with chloroquine showed reduced methotrexate bioavailability (median AUC ratio 1.6) 5, suggesting the interaction may vary based on formulation and timing.

Clinical Implications

The combination is commonly used in rheumatoid arthritis and has shown:

• Enhanced efficacy compared to either drug alone 6, 7
• The reduced Cmax may actually decrease acute liver toxicity 4
• The increased AUC provides sustained therapeutic effects 4

Management Recommendations

• Monitor more frequently for methotrexate adverse effects, especially:
  • Liver function tests monthly (rather than every 2-3 months)
  • Complete blood counts every 2-4 weeks initially
  • Renal function every 2-3 months
• Exercise extra vigilance if renal function is decreased 4
• This combination is acceptable but requires enhanced monitoring 1, 8, 9

No Direct Interaction: Amoxicillin-Clavulanic Acid and Hydroxychloroquine

There is no documented direct pharmacokinetic or pharmacodynamic interaction between amoxicillin-clavulanic acid and hydroxychloroquine in the available evidence 3.

However, the FDA label notes that ampicillin (structurally related to amoxicillin) significantly reduced chloroquine bioavailability in healthy volunteers 3. While this interaction with hydroxychloroquine "cannot be ruled out," there is no clinical evidence of significant interaction.

Triple Therapy Considerations

When all three drugs are used together:

1. Primary concern: The amoxicillin-methotrexate interaction
2. Secondary concern: Enhanced methotrexate effects from hydroxychloroquine
3. Cumulative risk: Potential for additive hepatotoxicity 1

Monitoring Protocol for Triple Therapy

• Before initiating: CBC with differential, comprehensive metabolic panel, liver function tests
• During treatment:
  • CBC weekly for first month, then every 2 weeks
  • Liver function tests weekly
  • Renal function twice weekly
  • Monitor for mucositis, rash, fever, unusual bleeding
• Duration: Limit amoxicillin-clavulanic acid to shortest effective course
• Have leucovorin immediately available for rescue therapy

Common Pitfalls to Avoid

• Don't assume short-term antibiotic use is safe: Even brief courses of penicillins can cause methotrexate toxicity 2
• Don't rely on standard monitoring intervals: Increase frequency when drugs are combined
• Don't ignore mild symptoms: Early mucositis or cytopenias can rapidly progress
• Don't forget to check baseline renal function: 85% of methotrexate is renally excreted 1